Optinose
Mr. Neely joined Optinose in December 2017 as Vice President, Investor Relations. He brings 15 years of progressive experience in finance, investor relations and corporate communications in the pharmaceuticals industry. Mr. Neely previously served as Head of Investor Relations and Corporate Communications at Axovant Sciences, Prior to that he held roles at Endo International including Director of Investor Relations and Director of Financial, Planning, and Analysis. Prior to starting in the pharmaceuticals industry Mr. Neely held progressive roles in finance at AT&T supporting International and Consumer businesses.
Mr. Neely earned a Master of Arts in Applied Statistics, a Bachelor of Science in Mathematics, and a Bachelor of Science in Economics from the University of Pittsburgh.
This person is not in any offices
Optinose
1 followers
Optinose is a specialty pharmaceutical company focused on creating and bringing to market innovative products for patients with diseases treated by ear, nose, and throat (ENT) and allergy specialists.